You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Novartis' (NVS) breast cancer drug, Kisqali, gets FDA approval as first-line treatment for pre-, peri- or post-menopausal women with HR+/HER2- advanced breast cancer.
Duke Energy's (DUK) plan to pass tax savings to customers is in sync with its commitment to help them manage electricity costs through lower bills and energy-efficiency programs.
Union Pacific Corporation's (UNP) second-quarter results benefit from increased freight revenues. However, deterioration in operating ratio remains a concern.
Neogen (NEOG) sticks to its four-pronged growth strategy for steady progress. Also, the company's accretive buyouts and its broader international base are a boon.
Nokia (NOK) joins forces with Philippines' Globe Telecom to help the latter deliver cloud-native business services, allowing enterprises to move seamlessly to the cloud.
CTI BioPharma (CTIC) conducts Type B meeting with the FDA to discuss a regulatory pathway for its lead pipeline candidate Pacritinib, currently under study for the treatment of myelofibrosis.
GE's operating segment, GE Aviation enters into a deal with Teradata (TDC) to serve as the sole provider of Teradata products and services for commercial aviation markets.
Although Travelers' (TRV) Q2 results suffer a year-over-year bottom-line deterioration, higher premiums as well as investment income drive the company's top line.
Increase in prices charged to customers, tax benefits, positive impact of acquisitions are likely to drive Waste Connections' (WCN) second-quarter 2018 results.
Las Vegas Sands' (LVS) The Venetian Macao and Sands Cotai Central segments perform impressively, which in turn is likely to boost the company's second-quarter results.
Devon (DVN) completes the divestiture of its ownership interests in the midstream assets, and will utilize the proceeds to strengthen operation, and increase the value of its shareholders.
The Barkawi Management Consultants acquisition is part of Genpact's (G) ongoing efforts to expand global supply chain management transformation expertise.
Zacks.com Most Recent Articles
First Horizon (FHN) Q2 Earnings in Line, Expenses Flare Up (Revised)
Analyst Blog
by Zacks Equity Research
First Horizon's (FHN) Q2 net income declines year over year on account of elevated expenses. However, net interest margin expands.
RF FHN TRMK BXS
Novartis' (NVS) Kisqali Gets FDA Nod for Label Expansion
Analyst Blog
by Zacks Equity Research
Novartis' (NVS) breast cancer drug, Kisqali, gets FDA approval as first-line treatment for pre-, peri- or post-menopausal women with HR+/HER2- advanced breast cancer.
RHHBY NVS GSK ONCE
Here's Why Investors Should Hold Stericycle (SRCL) Stock Now
Analyst Blog
by Zacks Equity Research
Stericycle (SRCL) looks promising on the back of its strategic acquisitions in both domestic and international markets.
WEX PAYX SRCL IQV
Baker Hughes to Divest NGS Business for $375M via 2 Deals
Analyst Blog
by Zacks Equity Research
Baker Hughes (BHGE) agrees to sell Natural Gas Solutions Business to two firms, namely First Reserve and Pietro Fiorentini, for $375 million.
GE BP EOG BHGE
Illinois Tool Works (ITW) Q2 Earnings: What's in Store?
Analyst Blog
by Zacks Equity Research
Illinois Tool's (ITW) Q2 earnings might benefit from robust revenues and ongoing enterprise initiatives. However, input cost inflation and rising freight charges remain drags.
ATKR ETN GGG ITW
Google to Take EU Ruling in Stride
Analyst Blog
by Sejuti Banerjea
Here's why investors shrugged off the $5 billion fine the EU slapped on Google.
AMZN GOOGL AAPL
Roche's Tecentriq Met Primary Goal in First-Line NSCLC Study
Analyst Blog
by Zacks Equity Research
Roche's (RHHBY) late-stage lung cancer study on immuno-oncology drug, Tecentriq, meets its co-primary endpoint of progression-free survival (PFS).
RHHBY BMY NVS MRK
Duke Energy Unit Files for New Rate, to Distribute Savings
Analyst Blog
by Zacks Equity Research
Duke Energy's (DUK) plan to pass tax savings to customers is in sync with its commitment to help them manage electricity costs through lower bills and energy-efficiency programs.
NEE SO DUK AGR
Cohen & Steers' (CNS) Q2 Earnings Miss, Expenses Flare Up
Analyst Blog
by Zacks Equity Research
Cohen & Steers' (CNS) Q2 earnings increase year over year on higher revenues. However, mounting expenses and declining AUM remain concerns.
TROW APO CNS ARES
Nucor's (NUE) Earnings, Revenues Trail Estimates in Q2
Analyst Blog
by Zacks Equity Research
Nucor (NUE) witnessed strong performance in its steel mills unit in Q2, but its results missed expectations.
MEOH KMG BHP NUE
Dover (DOV) Q2 Earnings & Sales Beat Estimates, Rise Y/Y
Analyst Blog
by Zacks Equity Research
Dover's (DOV) 2018 performance will benefit from cost-reduction initiatives and focus on product digitization, e-commerce and new product development.
ROP DOV GTLS WBT
Union Pacific (UNP) Q2 Earnings Surpass Estimates, Up Y/Y
Analyst Blog
by Zacks Equity Research
Union Pacific Corporation's (UNP) second-quarter results benefit from increased freight revenues. However, deterioration in operating ratio remains a concern.
UNP CNI NSC GWR
FuelCell Energy (FCEL) to Ramp Up Annual Output to 55MW
Analyst Blog
by Zacks Equity Research
FuelCell Energy (FCEL) to augment its annual production by 120% to 55MW for meeting the surge in demand for clean energy.
BLDP PLUG OXY FCEL
Alliance Data (ADS) Q2 Earnings Top, Tweaks Revenue View
Analyst Blog
by Zacks Equity Research
Alliance Data's (ADS) second quarter reflects improved performance across all its three segments.
WEX MA FIS ADS
Neogen (NEOG) Earnings and Revenues Beat Estimates in Q4
Analyst Blog
by Zacks Equity Research
Neogen (NEOG) sticks to its four-pronged growth strategy for steady progress. Also, the company's accretive buyouts and its broader international base are a boon.
ITGR NEOG GHDX ALGN
Nokia's Nuage Networks Partners Philippines' Globe Telecom
Analyst Blog
by Zacks Equity Research
Nokia (NOK) joins forces with Philippines' Globe Telecom to help the latter deliver cloud-native business services, allowing enterprises to move seamlessly to the cloud.
NOK CMTL T MU
CTI BioPharma Tanks Post Type B Talks on Pacritinib With FDA
Analyst Blog
by Zacks Equity Research
CTI BioPharma (CTIC) conducts Type B meeting with the FDA to discuss a regulatory pathway for its lead pipeline candidate Pacritinib, currently under study for the treatment of myelofibrosis.
INCY CTIC BLRX ACRX
Is a Beat in the Cards for Centene (CNC) in Q2 Earnings?
Analyst Blog
by Zacks Equity Research
Centene's (CNC) Q2 earnings is likely to gain from higher membership and revenues from Government business.
ALKS MGLN CNC ALGN
GE Extends Partnership With Teradata for Aviation Products
Analyst Blog
by Zacks Equity Research
GE's operating segment, GE Aviation enters into a deal with Teradata (TDC) to serve as the sole provider of Teradata products and services for commercial aviation markets.
TDC GE RAVN BHGE
Travelers (TRV) Q2 Earnings Miss & Down Y/Y, Revenues Top
Analyst Blog
by Zacks Equity Research
Although Travelers' (TRV) Q2 results suffer a year-over-year bottom-line deterioration, higher premiums as well as investment income drive the company's top line.
MTG RLI TRV PGR
Waste Connections (WCN) to Report Q2 Earnings: What's Up?
Analyst Blog
by Zacks Equity Research
Increase in prices charged to customers, tax benefits, positive impact of acquisitions are likely to drive Waste Connections' (WCN) second-quarter 2018 results.
CAR WCN APTV IQV
Nucor's (NUE) Q2 Earnings Beat, Revenues Miss Estimates
Tale of the Tape
by Zacks Equity Research
Nucor's (NUE) adjusted earnings were $2.13 per share for second-quarter 2018, which beat the Zacks Consensus Estimate of $2.10.
NUE
Is a Beat in Store for Las Vegas Sands (LVS) in Q2 Earnings?
Analyst Blog
by Zacks Equity Research
Las Vegas Sands' (LVS) The Venetian Macao and Sands Cotai Central segments perform impressively, which in turn is likely to boost the company's second-quarter results.
LVS CHDN VFC ATVI
Devon Divests More Assets, Shareholders Continue to Benefit
Analyst Blog
by Zacks Equity Research
Devon (DVN) completes the divestiture of its ownership interests in the midstream assets, and will utilize the proceeds to strengthen operation, and increase the value of its shareholders.
ENLK ENLC DVN MUR
Genpact Inks Deal to Snap Up Barkawi Management Consultants
Analyst Blog
by Zacks Equity Research
The Barkawi Management Consultants acquisition is part of Genpact's (G) ongoing efforts to expand global supply chain management transformation expertise.
WEX PAYX G IQV
Netflix Forays Into Audio Streaming With SiriusXM Partnership
Analyst Blog
by Zacks Equity Research
Netflix (NFLX) announces partnership with SiriusXM to launch its comedy focused channel.
AMZN NFLX SIRI AAPL
Company News For Jul 19, 2018
Corporate Summary
by Zacks Equity Research
Companies in the news are: ASML, MTG, GWW and NOK
NOK MTG ASML GWW
J. Jill, Tupperware, Suncor, IBM, eBay and American Express highlighted as Zacks Bull and Bear of the Day
Press Releases
by Zacks Equity Research
J. Jill, Tupperware, Suncor, IBM, eBay and American Express highlighted as Zacks Bull and Bear of the Day
IBM TUP EBAY
Positive Start to Q2 Earnings Season
Earnings Outlook
by Sheraz Mian
Total earnings for the 48 index members that have reported Q2 results are up +23%.
MS
Options Trading Around Earnngs is Not a Zero-Sum Game
Know Your Options
by David Borun
The timing and placement of hedge trades is just as important as the initial options trade
NFLX